Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph H Gleiter

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Plos One|October 15, 2013
Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietinAli Lourhmati, Gayane H Buniatian, Christina Paul, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Analytica Chimica Acta|May 27, 2008
Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancerDino Bullinger, Holger Fröhlich, Fabian Klaus, et al.
BMC Cancer|April 7, 2009
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selectionCarsten Henneges, Dino Bullinger, Richard Fux, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical studyRichard Fux, Klaus Mörike, Anne M T Pröhmer, et al.
Pharmacogenetics|January 5, 2002
Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphismMarkus Lutz, Matthias Schwab, Ernst-Ulrich Griese, et al.
Pharmacogenetics|May 7, 2004
Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteersJulia Kirchheiner, Mike Ufer, Ev-Charlotte Walter, et al.
Journal of Clinical Pharmacology|March 24, 2010
Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosisJoan M Korth-Bradley, Susan J Baird-Bellaire, Alain A Patat, et al.
American Journal of Physiology. Renal Physiology|September 15, 2007
Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxiaAlmut Grenz, Hua Zhang, Jochen Weingart, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2019
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive RatsHenning J Drews, Konstantin Yenkoyan, Ali Lourhmati, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Plos One|October 15, 2013
Age-dependent astroglial vulnerability to hypoxia and glutamate: the role for erythropoietinAli Lourhmati, Gayane H Buniatian, Christina Paul, et al.
Journal of Clinical Pharmacology|December 29, 2006
Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitorThomas D Bethke, Gabriele M Böhmer, Robert Hermann, et al.
Analytica Chimica Acta|May 27, 2008
Bioinformatical evaluation of modified nucleosides as biomedical markers in diagnosis of breast cancerDino Bullinger, Holger Fröhlich, Fabian Klaus, et al.
BMC Cancer|April 7, 2009
Prediction of breast cancer by profiling of urinary RNA metabolites using Support Vector Machine-based feature selectionCarsten Henneges, Dino Bullinger, Richard Fux, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical studyRichard Fux, Klaus Mörike, Anne M T Pröhmer, et al.
Pharmacogenetics|January 5, 2002
Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphismMarkus Lutz, Matthias Schwab, Ernst-Ulrich Griese, et al.
Pharmacogenetics|May 7, 2004
Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteersJulia Kirchheiner, Mike Ufer, Ev-Charlotte Walter, et al.
Journal of Clinical Pharmacology|March 24, 2010
Pharmacokinetics and safety of a single intravenous dose of the antibiotic tigecycline in patients with cirrhosisJoan M Korth-Bradley, Susan J Baird-Bellaire, Alain A Patat, et al.
American Journal of Physiology. Renal Physiology|September 15, 2007
Lack of effect of extracellular adenosine generation and signaling on renal erythropoietin secretion during hypoxiaAlmut Grenz, Hua Zhang, Jochen Weingart, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|February 24, 2019
Intranasal Losartan Decreases Perivascular Beta Amyloid, Inflammation, and the Decline of Neurogenesis in Hypertensive RatsHenning J Drews, Konstantin Yenkoyan, Ali Lourhmati, et al.
Pageof 7